‘Regd. Office: Dr tut Prahtiatn Lat. Rina, Sector-18, Rohirs, New Oethi! 10085
Wete wwrauinipathintss com, CIN: L7SB99OL UISRLCOOS 388
Name : ARVEEN KAUR Age : 34 Years
Lab No. : 194201169 Gender : Female
Ref By : DR YOGINDER GUPTA Reported + 27/04/2025 03:42:25 PM
Collected  : NNMMo2:36:00 pm Report Status: Interim
Alc Status ;P
Collected At ; S43-SEHGAL NEO HOSPITAL Processed At ; Dr. Lal Pathlabs Ltd.
8-362,363,364, Meera bagh, Outer Ring Road, Meera Bagh, New Delhi - 110063
Paschim Vihar, New Deihi- 110063, Tel: 014-
45565656
Id : 353922/
Test Report ue
|LIVER & KIDNEY PANEL, SERUM 1
| Calcium, Serum 9.00 mg/d 88-106
(Arsenezo fil)
| Phosphorus 3.00 mg/d 24-44
| (Molybdate Uv)
| Sodium 137.05 mEq/L 136 - 146
{Indwect ISE)
| Potassium 4.24 mEq/L 3.5-5.1
| (Indirect ISE)
Chloride 105.44 mEq/L 101 - 109
| (indirect SE)
Alkaline Phosphatase (ALP) 62.00 UL 30-120
| Wee} My
Remarks: Followup & clinical correlation
Note:
* GFR, estimated (eGFR) calculated using the 2021 CKD-EPI creatinine equation and GFR Category r: om
per KDIGO guideline 2012. ‘ g
* @GFR category G1 or G2 does not fulfil the criteria for CKD, in the absence of evidence of kid
* The BUN-to-creatinine ratio is used to differentiate prerenal and postrenal azotemia from renal
Because of considerable variability, it should be used only as a rough guide. Normally, the BUN/creatinine ratio is
about 10:1 j
* If estimated GFR is 60 to <90:
Advise: CKD Risk Map (21014) 5
* If estimated GFR is <60:
Advise: 1. CKD Risk Map (Z1014) 2. Cystatin C, serum (B173)
Result’/s to follow:
URINE EXAMINATION, ROUTINE; URINE, R/E (U001)
= N a
we
OMcR/14886
Dr. Nitika Kuman
NO, Pathology
Chief of Lab.
pre End Of Report mans
Page 5086 7 is: ==
HAMIL